0
     

Report Added
Report already added
Europe Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

Europe Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

Europe single cell multiomics market was valued at $ 527.9 million in 2021 and will grow by 18.0% annually over 2021-2031, driven by the rising prevalence of chronic diseases along with the aging population, the widespread product adoption for visualization and analysis, technological advancements along with the rising R&D investment, and the significant growth in the pharmaceutical industry especially personalized medication.
Highlighted with 39 tables and 77 figures, this 150-page report “Europe Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe single cell multiomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
•Market Structure
•Growth Drivers
•Restraints and Challenges
•Emerging Product Trends & Market Opportunities
•Porter’s Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe single cell multiomics market in every aspect of the classification from perspectives of Product Type, Omics Type, Application, Sample Type, Workflow, End User, and Country.

Based on Product Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Instruments
•Consumables
•Software

Based on Omics Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Single Cell Genomics (SCG)
•Single Cell Transcriptomics (SCT)
•Single Cell Proteomics (SCP)
•Single Cell Metabolomics (SCM)

By Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Clinical Research
oOncology
oCell Therapy
oImmunology
oNeurology
oCell Biology
oOther Types of Clinical Research
•Translation Research
•Synthetic Biology

By Sample Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Human Samples
oCancer Tissues
oStem Cells
oImmune Cells
oBrain Cells
oOther Human Samples
•Animal Samples
•Microbial Samples

By Workflow, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Single-Cell Isolation and Dispensing
oFluorescence-Activated Cell Sorting (FACS)
oMicrofluidics
oMagnetic-Activated Cell Sorting (MACS)
oRandom Seeding
oManual Cell Picking
oLaser Capture Microdissection
oOther Technologies of Single-Cell Isolation and Dispensing
•Single-Cell Analysis
oPolymerase Chain Reaction
oNext-Generation Sequencing
oMass Cytometry
oMass Spectrometry
oOther Technologies of Single-Cell Analysis

By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Research and Academic Laboratories
•Biopharmaceutical and Biotech Companies
•Contract Research Organizations (CROs)
•Other End Users

Geographically, the following national/local markets are fully investigated:
•Germany
•UK
•France
•Spain
•Italy
•Netherlands
•Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Omics Type, Workflow and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:
10x Genomics, Inc.
1CellBio, Inc.
Becton, Dickinson and Company
Berkeley Lights, Inc.
BGI Genomics Co., Ltd.
Bio-Rad Laboratories, Inc.
Bio-Techne Corporation
BioTuring, Inc.
Danaher Corporation (Cytiva Life Sciences)
Dolomite Bio
Fluidigm Corporation
Fluxion Biosciences
Illimina, Inc
Mission Bio, Inc.
Namocell, Inc.
NanoString Technologies, Inc.
Parse Biosciences, Inc.
Proteona
Qiagen N.V.
RareCyte, Inc.
Scipio Biosciences SAS
Shilps Sciences
Takara Bio Inc. (Takara Holdings)
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table of Contents

1 Introduction8
1.1 Industry Definition and Research Scope8
1.1.1 Industry Definition8
1.1.2 Research Scope9
1.2 Research Methodology12
1.2.1 Overview of Market Research Methodology12
1.2.2 Market Assumption13
1.2.3 Secondary Data13
1.2.4 Primary Data13
1.2.5 Data Filtration and Model Design14
1.2.6 Market Size/Share Estimation15
1.2.7 Research Limitations16
1.3 Executive Summary17
2 Market Overview and Dynamics20
2.1 Market Size and Forecast20
2.1.1 Impact of COVID-19 on World Economy21
2.1.2 Impact of COVID-19 on the Market25
2.2 Major Growth Drivers27
2.3 Market Restraints and Challenges35
2.4 Emerging Opportunities and Market Trends38
2.5 Porter’s Fiver Forces Analysis42
3 Segmentation of Europe Market by Product Type46
3.1 Market Overview by Product Type46
3.2 Instruments48
3.3 Consumables49
3.4 Software50
4 Segmentation of Europe Market by Omics Type51
4.1 Market Overview by Omics Type51
4.2 Single Cell Genomics (SCG)53
4.3 Single Cell Transcriptomics (SCT)54
4.4 Single Cell Proteomics (SCP)55
4.5 Single Cell Metabolomics (SCM)56
5 Segmentation of Europe Market by Application57
5.1 Market Overview by Application57
5.2 Clinical Research59
5.2.1 Oncology61
5.2.2 Cell Therapy62
5.2.3 Immunology63
5.2.4 Neurology64
5.2.5 Cell Biology65
5.2.6 Other Types of Clinical Research66
5.3 Translation Research67
5.4 Synthetic Biology68
6 Segmentation of Europe Market by Sample Type69
6.1 Market Overview by Sample Type69
6.2 Human Samples71
6.2.1 Cancer Tissues73
6.2.2 Stem Cells74
6.2.3 Immune Cells75
6.2.4 Brain Cells76
6.2.5 Other Human Samples77
6.3 Animal Samples78
6.4 Microbial Samples79
7 Segmentation of Europe Market by Workflow80
7.1 Market Overview by Workflow80
7.2 Single-Cell Isolation and Dispensing82
7.2.1 Fluorescence-Activated Cell Sorting (FACS)84
7.2.2 Microfluidics85
7.2.3 Magnetic-Activated Cell Sorting (MACS)86
7.2.4 Random Seeding87
7.2.5 Manual Cell Picking88
7.2.6 Laser Capture Microdissection89
7.2.7 Other Technologies of Single-Cell Isolation and Dispensing90
7.3 Single-Cell Analysis91
7.3.1 Polymerase Chain Reaction93
7.3.2 Next-Generation Sequencing94
7.3.3 Mass Cytometry95
7.3.4 Mass Spectrometry96
7.3.5 Other Technologies of Single-Cell Analysis97
8 Segmentation of Europe Market by End User98
8.1 Market Overview by End User98
8.2 Research and Academic Laboratories100
8.3 Biopharmaceutical and Biotech Companies101
8.4 Contract Research Organizations (CROs)102
8.5 Other End Users103
9 European Market 2021-2031 by Country104
9.1 Overview of European Market104
9.2 Germany107
9.3 U.K.109
9.4 France111
9.5 Spain113
9.6 Italy115
9.7 Netherlands117
9.8 Rest of European Market119
10 Competitive Landscape121
10.1 Overview of Key Vendors121
10.2 New Product Launch, Partnership, Investment, and M&A124
10.3 Company Profiles125
10x Genomics, Inc.125
1CellBio, Inc.127
Becton, Dickinson and Company128
Berkeley Lights, Inc.129
BGI Genomics Co., Ltd.130
Bio-Rad Laboratories, Inc.131
Bio-Techne Corporation132
BioTuring, Inc.133
Danaher Corporation (Cytiva Life Sciences)134
Dolomite Bio135
Fluidigm Corporation136
Fluxion Biosciences137
Illimina, Inc138
Mission Bio, Inc.139
Namocell, Inc.140
NanoString Technologies, Inc.141
Parse Biosciences, Inc.142
Proteona143
Qiagen N.V.144
RareCyte, Inc.145
Scipio Biosciences SAS146
Shilps Sciences147
Takara Bio Inc. (Takara Holdings)148
Thermo Fisher Scientific Inc.149
RELATED REPORTS150

List of Figures:

Figure 1. Research Method Flow Chart12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation15
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-203117
Figure 4. Europe Single Cell Multiomics Market, 2021-2031, $ mn20
Figure 5. Impact of COVID-19 on Business25
Figure 6. Primary Drivers and Impact Factors of Europe Single Cell Multiomics Market27
Figure 7. Leading Causes of Death in the World, 2000 and 2019, million30
Figure 8. Total Reported Cases of Lyme Disease by Year in U.S., 1998-201931
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million33
Figure 10. World Population 65 and Over, % of Total Population, 1950-206033
Figure 11. Primary Restraints and Impact Factors of Europe Single Cell Multiomics Market35
Figure 12. Investment Opportunity Analysis39
Figure 13. Porter’s Fiver Forces Analysis of Europe Single Cell Multiomics Market42
Figure 14. Breakdown of Europe Single Cell Multiomics Market by Product Type, 2021-2031, % of Revenue47
Figure 15. Europe Addressable Market Cap in 2022-2031 by Product Type, Value ($ mn) and Share (%)47
Figure 16. Europe Single Cell Multiomics Market by Product Type: Instruments, 2021-2031, $ mn48
Figure 17. Europe Single Cell Multiomics Market by Product Type: Consumables, 2021-2031, $ mn49
Figure 18. Europe Single Cell Multiomics Market by Product Type: Software, 2021-2031, $ mn50
Figure 19. Breakdown of Europe Single Cell Multiomics Market by Omics Type, 2021-2031, % of Sales Revenue52
Figure 20. Europe Addressable Market Cap in 2022-2031 by Omics Type, Value ($ mn) and Share (%)52
Figure 21. Europe Single Cell Multiomics Market by Omics Type: Single Cell Genomics (SCG), 2021-2031, $ mn53
Figure 22. Europe Single Cell Multiomics Market by Omics Type: Single Cell Transcriptomics (SCT), 2021-2031, $ mn54
Figure 23. Europe Single Cell Multiomics Market by Omics Type: Single Cell Proteomics (SCP), 2021-2031, $ mn55
Figure 24. Europe Single Cell Multiomics Market by Omics Type: Single Cell Metabolomics (SCM), 2021-2031, $ mn56
Figure 25. Breakdown of Europe Single Cell Multiomics Market by Application, 2021-2031, % of Sales Revenue58
Figure 26. Europe Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)58
Figure 27. Europe Single Cell Multiomics Market by Application: Clinical Research, 2021-2031, $ mn59
Figure 28. Europe Single Cell Multiomics Market by Clinical Research: Oncology, 2021-2031, $ mn61
Figure 29. Europe Single Cell Multiomics Market by Clinical Research: Cell Therapy, 2021-2031, $ mn62
Figure 30. Europe Single Cell Multiomics Market by Clinical Research: Immunology, 2021-2031, $ mn63
Figure 31. Europe Single Cell Multiomics Market by Clinical Research: Neurology, 2021-2031, $ mn64
Figure 32. Europe Single Cell Multiomics Market by Clinical Research: Cell Biology, 2021-2031, $ mn65
Figure 33. Europe Single Cell Multiomics Market by Clinical Research: Other Types of Clinical Research, 2021-2031, $ mn66
Figure 34. Europe Single Cell Multiomics Market by Application: Translation Research, 2021-2031, $ mn67
Figure 35. Europe Single Cell Multiomics Market by Application: Synthetic Biology, 2021-2031, $ mn68
Figure 36. Breakdown of Europe Single Cell Multiomics Market by Sample Type, 2021-2031, % of Revenue70
Figure 37. Europe Addressable Market Cap in 2022-2031 by Sample Type, Value ($ mn) and Share (%)70
Figure 38. Europe Single Cell Multiomics Market by Sample Type: Human Samples, 2021-2031, $ mn71
Figure 39. Europe Single Cell Multiomics Market by Human Samples: Cancer Tissues, 2021-2031, $ mn73
Figure 40. Europe Single Cell Multiomics Market by Human Samples: Stem Cells, 2021-2031, $ mn74
Figure 41. Europe Single Cell Multiomics Market by Human Samples: Immune Cells, 2021-2031, $ mn75
Figure 42. Europe Single Cell Multiomics Market by Human Samples: Brain Cells, 2021-2031, $ mn76
Figure 43. Europe Single Cell Multiomics Market by Human Samples: Other Human Samples, 2021-2031, $ mn77
Figure 44. Europe Single Cell Multiomics Market by Sample Type: Animal Samples, 2021-2031, $ mn78
Figure 45. Europe Single Cell Multiomics Market by Sample Type: Microbial Samples, 2021-2031, $ mn79
Figure 46. Breakdown of Europe Single Cell Multiomics Market by Workflow, 2021-2031, % of Revenue81
Figure 47. Europe Addressable Market Cap in 2022-2031 by Workflow, Value ($ mn) and Share (%)81
Figure 48. Europe Single Cell Multiomics Market by Workflow: Single-Cell Isolation and Dispensing, 2021-2031, $ mn82
Figure 49. Europe Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Fluorescence-Activated Cell Sorting (FACS), 2021-2031, $ mn84
Figure 50. Europe Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Microfluidics, 2021-2031, $ mn85
Figure 51. Europe Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Magnetic-Activated Cell Sorting (MACS), 2021-2031, $ mn86
Figure 52. Europe Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Random Seeding, 2021-2031, $ mn87
Figure 53. Europe Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Manual Cell Picking, 2021-2031, $ mn88
Figure 54. Europe Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Laser Capture Microdissection, 2021-2031, $ mn89
Figure 55. Europe Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Other Technologies of Single-Cell Isolation and Dispensing, 2021-2031, $ mn90
Figure 56. Europe Single Cell Multiomics Market by Workflow: Single-Cell Analysis, 2021-2031, $ mn91
Figure 57. Europe Single Cell Multiomics Market by Single-Cell Analysis: Polymerase Chain Reaction, 2021-2031, $ mn93
Figure 58. Europe Single Cell Multiomics Market by Single-Cell Analysis: Next-Generation Sequencing, 2021-2031, $ mn94
Figure 59. Europe Single Cell Multiomics Market by Single-Cell Analysis: Mass Cytometry, 2021-2031, $ mn95
Figure 60. Europe Single Cell Multiomics Market by Single-Cell Analysis: Mass Spectrometry, 2021-2031, $ mn96
Figure 61. Europe Single Cell Multiomics Market by Single-Cell Analysis: Other Technologies of Single-Cell Analysis, 2021-2031, $ mn97
Figure 62. Breakdown of Europe Single Cell Multiomics Market by End User, 2021-2031, % of Revenue98
Figure 63. Europe Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)99
Figure 64. Europe Single Cell Multiomics Market by End User: Research and Academic Laboratories, 2021-2031, $ mn100
Figure 65. Europe Single Cell Multiomics Market by End User: Biopharmaceutical and Biotech Companies, 2021-2031, $ mn101
Figure 66. Europe Single Cell Multiomics Market by End User: Contract Research Organizations (CROs), 2021-2031, $ mn102
Figure 67. Europe Single Cell Multiomics Market by End User: Other End Users, 2021-2031, $ mn103
Figure 68. Breakdown of European Single Cell Multiomics Market by Country, 2021 and 2031, % of Revenue105
Figure 69. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)106
Figure 70. Single Cell Multiomics Market in Germany, 2021-2031, $ mn107
Figure 71. Single Cell Multiomics Market in U.K., 2021-2031, $ mn109
Figure 72. Single Cell Multiomics Market in France, 2021-2031, $ mn111
Figure 73. Single Cell Multiomics Market in Spain, 2021-2031, $ mn113
Figure 74. Single Cell Multiomics Market in Italy, 2021-2031, $ mn115
Figure 75. Single Cell Multiomics Market in Netherlands, 2021-2031, $ mn117
Figure 76. Single Cell Multiomics Market in Rest of Europe, 2021-2031, $ mn119
Figure 77. Growth Stage of Europe Single Cell Multiomics Industry over the Forecast Period121

Report Title: Europe Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW